155 related articles for article (PubMed ID: 34747201)
1. Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart.
Shang R; Lal N; Lee CS; Zhai Y; Puri K; Seira O; Boushel RC; Sultan I; Räsänen M; Alitalo K; Hussein B; Rodrigues B
Am J Physiol Endocrinol Metab; 2021 Dec; 321(6):E753-E765. PubMed ID: 34747201
[TBL] [Abstract][Full Text] [Related]
2. Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization.
Shang R; Lee CS; Wang H; Dyer R; Noll C; Carpentier A; Sultan I; Alitalo K; Boushel R; Hussein B; Rodrigues B
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):177-191. PubMed ID: 38150518
[TBL] [Abstract][Full Text] [Related]
3. Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.
Chiu AP; Bierende D; Lal N; Wang F; Wan A; Vlodavsky I; Hussein B; Rodrigues B
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H82-H94. PubMed ID: 28986359
[TBL] [Abstract][Full Text] [Related]
4. Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.
Lal N; Chiu AP; Wang F; Zhang D; Jia J; Wan A; Vlodavsky I; Hussein B; Rodrigues B
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1163-H1175. PubMed ID: 28314760
[TBL] [Abstract][Full Text] [Related]
5. Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1.
Luo X; Li RR; Li YQ; Yu HP; Yu HN; Jiang WG; Li YN
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894135
[TBL] [Abstract][Full Text] [Related]
6. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
[TBL] [Abstract][Full Text] [Related]
7. Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases.
Kewalramani G; Puthanveetil P; Kim MS; Wang F; Lee V; Hau N; Beheshti E; Ng N; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E137-47. PubMed ID: 18460599
[TBL] [Abstract][Full Text] [Related]
8. Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression.
Nishida Y; Nishijima K; Yamada Y; Tanaka H; Matsumoto A; Fan J; Uda Y; Tomatsu H; Yamamoto H; Kami K; Kitajima S; Tanaka K
Metabolomics; 2021 Feb; 17(3):26. PubMed ID: 33594546
[TBL] [Abstract][Full Text] [Related]
9. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
10. Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease.
Pulinilkunnil T; Rodrigues B
Cardiovasc Res; 2006 Feb; 69(2):329-40. PubMed ID: 16307734
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease.
Puthanveetil P; Wan A; Rodrigues B
Crit Rev Clin Lab Sci; 2015; 52(3):138-49. PubMed ID: 25597500
[TBL] [Abstract][Full Text] [Related]
12. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
[TBL] [Abstract][Full Text] [Related]
13. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
Chiu AP; Wan A; Lal N; Zhang D; Wang F; Vlodavsky I; Hussein B; Rodrigues B
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):145-55. PubMed ID: 26586663
[TBL] [Abstract][Full Text] [Related]
16. Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.
Pulinilkunnil T; An D; Yip P; Chan N; Qi D; Ghosh S; Abrahani A; Rodrigues B
J Mol Cell Cardiol; 2004 Nov; 37(5):931-8. PubMed ID: 15522270
[TBL] [Abstract][Full Text] [Related]
17. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart.
Shang R; Rodrigues B
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356640
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Ewart HS; Carroll R; Severson DL
Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
